CDMO services
Lifecore develops, fills, and packages sterile injectable medicines for other drug companies, including work on formulation, process development, and manufacturing at its Minnesota facility.
Customers and revenue model
Lifecore Biomedical Inc
F:LDE
Lifecore Biomedical Inc
F:LDE
Price:
5.55
EUR
-0.89%
Market Closed
Market Cap:
€184.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Lifecore Biomedical Inc
F:LDE
|
US |
|
P
|
PNC Financial Services Group Inc
LSE:0KEF
|
US |
|
B
|
Bastogi SpA
F:BAOA
|
IT |
|
V
|
Vallourec SA
PAR:VK
|
FR |
|
Emetals Ltd
ASX:EMT
|
AU |
|
COG Financial Services Ltd
ASX:COG
|
AU |
|
SBM Offshore NV
F:IHCB
|
NL |
|
Stratasys Ltd
NASDAQ:SSYS
|
US |
|
DFI Retail Group Holdings Ltd
F:DFA1
|
HK |
|
S
|
Shin-Etsu Chemical Co Ltd
OTC:SHECY
|
JP |
|
K
|
Kumba Iron Ore Ltd
JSE:KIO
|
ZA |
|
B
|
Bidvest Group Ltd
JSE:BVT
|
ZA |
|
WisdomTree Inc
F:1WT
|
US |
|
SBA Communications Corp
NASDAQ:SBAC
|
US |
|
Rusolovo PAO
MOEX:ROLO
|
RU |
|
Y
|
Yellow Cake PLC
XMUN:0LZ
|
JE |
|
Angus Energy PLC
F:A3R
|
UK |
|
T
|
Transurban Group
OTC:TRAUF
|
AU |
|
DFI Retail Nusantara Tbk Pt
IDX:HERO
|
ID |
|
M
|
Merck & Co Inc
XMUN:6MK
|
US |
|
Covivio SA
F:F5D
|
FR |
|
SG Finserve Ltd
BSE:539199
|
IN |
|
Z
|
Zhong An Group Ltd
F:35Z
|
CN |
|
Molson Coors Canada Inc
TSX:TPX.B
|
CA |
Company Overview
Business Description
- Sector
- Health Care
- Industry
- Life Sciences Tools & Services
- Headquarters
- United States of America US
- Employees
- 400
- IPO date
- Feb 15, 1996
Lifecore Biomedical makes and packages sterile injectable medicines for other drug companies. It also manufactures hyaluronic acid, a key ingredient used in some eye, joint, and surgical products. The company sits in the middle of the pharmaceutical supply chain, helping customers turn drug formulas into finished, sterile products that can be sold to hospitals, clinics, and patients.
Its customers are drug developers and pharmaceutical companies that need outside help with manufacturing, especially for products that must be filled into vials or syringes in a clean, tightly controlled environment. Lifecore earns money by charging for contract manufacturing work, development services, and the sale of its hyaluronic acid-based materials. In other words, it gets paid both for making the product and for helping customers move it through the production process.
What makes the business different is that it combines two roles: a specialty ingredient maker and a sterile fill-finish manufacturer. That gives it technical know-how in both raw materials and finished dosage forms, which is useful for customers that need a partner with strict quality controls and experience handling sensitive injectable products.
Continue LDE Research
Other Lifecore Biomedical Inc listings:
